The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access.
暂无分享,去创建一个
M. Yigla | S. Reisner | F. Nakhoul | Z. Abassi | R. Gilman
[1] J. Krishnan,et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. , 2004, The New England journal of medicine.
[2] M. Yigla,et al. Pulmonary hypertension in patients with end-stage renal disease. , 2003, Chest.
[3] R. Naeije. Pulmonary vascular resistance. A meaningless variable? , 2003, Intensive care medicine.
[4] R. Naeije. Pulmonary vascular resistance , 2003 .
[5] N. Morrell,et al. Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. , 2002, Progress in cardiovascular diseases.
[6] J. Donohoe,et al. Reversal of pulmonary hypertension after ligation of a brachiocephalic arteriovenous fistula. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] T. Dschietzig,et al. Flow-induced pressure differentially regulates endothelin-1, urotensin II, adrenomedullin, and relaxin in pulmonary vascular endothelium. , 2001, Biochemical and biophysical research communications.
[8] N. Vaziri. Effect of chronic renal failure on nitric oxide metabolism. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] E. Mervaala,et al. Clinically important factors influencing endothelial function. , 2001, Medical science monitor : international medical journal of experimental and clinical research.
[10] S. Rich,et al. Primary pulmonary hypertension: a vascular biology and translational research "Work in progress". , 2000, Circulation.
[11] S. Oparil,et al. Endothelial dysfunction in the pulmonary vascular bed. , 2000, The American journal of the medical sciences.
[12] M. Yigla,et al. Background diseases in 671 patients with moderate to severe pulmonary hypertension. , 2000, The Israel Medical Association journal : IMAJ.
[13] A. Jardine,et al. The vascular endothelium in chronic renal failure. , 2000, Journal of nephrology.
[14] M. Hijmering,et al. Nitric oxide production is reduced in patients with chronic renal failure. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[15] A. Giaid. Nitric oxide and endothelin-1 in pulmonary hypertension. , 1998, Chest.
[16] L. Rubin,et al. Pathology and pathophysiology of primary pulmonary hypertension. , 1995, The American journal of cardiology.
[17] J. Stamler,et al. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. , 1994, Circulation.
[18] D. Stewart,et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. , 1993, The New England journal of medicine.
[19] Avid,et al. BOSENTAN THERAPY FOR PULMONARY ARTERIAL HYPERTENSION , 2002 .
[20] S. Oparil,et al. Endothelin and pulmonary hypertension. , 2000, Journal of cardiovascular pharmacology.
[21] W. Markiewicz,et al. Septal/free wall curvature ratio: a noninvasive index of pulmonary arterial pressure. , 1994, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.